Cannonau Corp. (OTCMKTS:CNNC) stock traded in a narrow range on Thursday, after a down session on Wednesday. CNNC needs an up day to get back on track.
On Thursday, CNNC was up 4.69% or $0.09 to end the session at $2.01. Total volume for the session stood at 91,957 shares, almost half compared to its 30-day average volume of 162,326 shares. The stock opened at $1.95 and moved within a narrow range of $1.92- 2.10.
It develops cannabidiol-based products. CNNC’s mission is to produce high-quality, pure, and natural cannabidiol products.
CNNC Releases News
Cannonau Corporation Announces New Medical Advisor
- Cannonau Corp has announced that it has appointed Dr. Douglas Pitchford, MD, as its new Medical Advisor.
- Born in New Jersey,Dr. Douglas Pitchford graduated from Rutgers Medical School in 1985, and he has over 36 years of experience in the medical field. His specialties include Anesthesiology, Pain Management, and Pain Medicine.
- As a Medical Advisor,Dr. Douglas Pitchford will utilize his vast experience to evaluate, critique, and communicate regarding Cannonau products.
Carmen Carbona, Cannonau’s President, and CEO commented: “Dr. Douglas Pitchford MD. is an important addition to our expanding team of experts. Utilizing his insight, scientific direction, and expertise will improve efficiencies, promote company growth and benefit our customers and shareholders.”